The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model

dc.contributor.author	Kaya, E.
dc.contributor.author	Kibar, Y.
dc.contributor.author	Yilmaz, S.
dc.contributor.author	Ozcan, A.
dc.contributor.author	Kopru, B.
dc.contributor.author	Ebiloglu, T.
dc.contributor.author	Irkilata, H.C.
dc.date.accessioned	2021-12-21T08:41:12Z
dc.date.available	2021-12-21T08:41:12Z
dc.date.issued	2017
dc.identifier.issn	19201214
dc.identifier.uri	https://doi.org/10.5489/cuaj.4489
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1355
dc.description.abstract	Introduction: We aimed to evaluate whether or not mitomycin-C (MMC) has an antifibrotic effect on transforming growth factor-beta (TGF-β)-induced Peyronie's disease (PD) in a rat model. Methods: Eighteen 12-week-old male Sprague-Dawley rats were divided i
dc.language.iso	English
dc.publisher	Canadian Urological Association
dc.rights	All Open Access, Bronze, Green
dc.title	The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model
dc.type	Article
dc.relation.journal	Canadian Urological Association Journal
dc.identifier.issue	11
dc.identifier.startpage	E441
dc.identifier.endpage	E445
dc.identifier.volume	11
dc.identifier.doi	10.5489/cuaj.4489
dc.relation.issue	11
dc.relation.volume	11